HomeCompareGMDA vs PM

GMDA vs PM: Dividend Comparison 2026

GMDA yields 6116.21% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GMDA wins by $442825559222013.75M in total portfolio value
10 years
GMDA
GMDA
● Live price
6116.21%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$442825559222013.81M
Annual income
$429,026,802,483,037,700,000.00
Full GMDA calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — GMDA vs PM

📍 GMDA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGMDAPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GMDA + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GMDA pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GMDA
Annual income on $10K today (after 15% tax)
$519,877.68/yr
After 10yr DRIP, annual income (after tax)
$364,672,782,110,582,000,000.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, GMDA beats the other by $364,672,782,110,582,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GMDA + PM for your $10,000?

GMDA: 50%PM: 50%
100% PM50/50100% GMDA
Portfolio after 10yr
$221412779611006.94M
Annual income
$214,513,401,241,518,830,000.00/yr
Blended yield
96.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

GMDA
Analyst Ratings
7
Buy
1
Hold
Consensus: Buy
Altman Z
-12.9
Piotroski
2/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GMDA buys
0
PM buys
0
No recent congressional trades found for GMDA or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGMDAPM
Forward yield6116.21%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$442825559222013.81M$49.6K
Annual income after 10y$429,026,802,483,037,700,000.00$2,492.02
Total dividends collected$441897573176239.63M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: GMDA vs PM ($10,000, DRIP)

YearGMDA PortfolioGMDA Income/yrPM PortfolioPM Income/yrGap
1← crossover$622,321$611,620.80$11,648$408.29+$610.7KGMDA
2$36,238,251$35,572,368.18$13,589$495.90+$36.22MGMDA
3$1,974,670,479$1,935,895,550.07$15,877$603.21+$1974.65MGMDA
4$100,701,235,006$98,588,337,593.13$18,580$734.88+$100701.22MGMDA
5$4,806,495,889,234$4,698,745,567,778.20$21,781$896.75+$4806495.87MGMDA
6$214,743,265,021,614$209,600,314,420,132.84$25,578$1,096.12+$214743265.00MGMDA
7$8,981,610,447,341,976$8,751,835,153,768,850.00$30,092$1,342.17+$8981610447.31MGMDA
8$351,707,912,645,944,000$342,097,589,467,288,100.00$35,470$1,646.46+$351707912645.91MGMDA
9$12,896,034,335,491,684,000$12,519,706,868,960,524,000.00$41,892$2,023.58+$12896034335491.64MGMDA
10$442,825,559,222,013,800,000$429,026,802,483,037,700,000.00$49,578$2,492.02+$442825559222013.75MGMDA

GMDA vs PM: Complete Analysis 2026

GMDAStock

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. In addition, the company is developing NK cell pipeline comprising GDA-301, GDA-401, GDA-501, and GDA-601 to treat hematologic malignancies and solid tumors. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

Full GMDA Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this GMDA vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GMDA vs SCHDGMDA vs JEPIGMDA vs OGMDA vs KOGMDA vs MAINGMDA vs MOGMDA vs BTIGMDA vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.